Mutual Fund Ownership
Ownership as on: Sun, 30 Jun, 2024

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)3.37
% of AUM8.46%

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)538.75
% of AUM7.52%

SBI Healthcare Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)172.29
% of AUM6.59%

SBI Magnum Global Fund Regular Growth

NA
Equity
Amount Invested (Cr.)387.65
% of AUM6.09%

LIC MF Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.58
% of AUM5.92%

FAQs about Divis Laboratories share price

Divis Laboratories is trading at 4595.20 as on Fri Jun 28 2024 10:29:48. This is 1.53% upper as compared to its previous closing price of 4526.10.

The market capitalization of Divis Laboratories is 121988.12 Cr as on Fri Jun 28 2024 10:29:48.

The average broker rating on Divis Laboratories is Sell. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 7 analysts have given a hold rating
  • 6 analysts have given a sell rating
  • 5 analysts have given a strong sell rating

The 52 wk high for Divis Laboratories is 4644.00 whereas the 52 wk low is 3300.00

Divis Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 57.16
  • Sector P/E: 41.74
  • Dividend Yield: 0.66%
  • D/E ratio: 0.00

Divis Laboratories reported a net profit of 1600.00 Cr in 2024.

Recommended For You
Trending Stocks
3,131.85+70.75(2.31%)
990.10+18.10(1.86%)
2,920.00+37.85(1.31%)
1,463.80-39.20 (-2.61%)
1,262.45-26.40 (-2.05%)
HomeMarketsPremiumInstant LoanMint Shorts